Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are ...

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...

ORLANDO, Fla. — The old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with the potential to reduce ...

The PCE was developed by the American College of Cardiology and American Heart Association and uses factors such as age, sex, ...

Among 34,239 matched pairs, the risk of incident nonproliferative diabetic retinopathy was not different between patients taking empagliflozin or DPP-4 inhibitors (HR 1.04, 95% CI 0.94-1.15) over a ...

While rapid weight-loss with bariatric surgery or drugs might temporarily worsen diabetic retinopathy as blood sugar levels are rapidly corrected, the low overall risk likely doesn't outweigh the ...

Advancements that could lead to earlier diagnosis and treatment for diabetic retinopathy, a common complication that affects the eyes, have been identified by a multi-department research team from ...

By actively leading awareness on diabetic retinopathy, Barraquer aims to shift the conversation from reaction to prevention.

Patients with diabetes should undergo careful retinal evaluation for the first year following cataract surgery. The risk of diabetic retinopathy (DR) progression increases after cataract surgery, ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

Regular eye exams are important in detecting early signs of diabetic retinopathy to prevent vision loss. Since diabetic retinopathy doesn’t cause symptoms in its early stages, diagnostic testing can ...